With the increasing impact of coronaviruses around the world, large pharma companies have also stepped up the practice of making vaccines. Many companies are claiming to launch the vaccine by the end of this year or early next year. However, till now, the vaccines of Oxford University and Astra Zeneca Company, considered to be at the forefront of this race, have lagged behind. American company Pfizer-BioNotech is now jointly in the forefront of making vaccines. It is believed that these two companies will find out the effects of the vaccine by October. After this, if it is approved for emergency use, then Pfizer’s Corona vaccine may hit the US markets by November or December.
In the race for Corona Vaccine, now the US company is also at number two. Moderna is currently in a third phase trial of her potential vaccine. The company expects to know its impact by December. After emergency approval, the vaccine may come to market by the end of December or early January 2021.
There may be some delay in the potential vaccine coming to market of Oxford University and Astra Janeca, which are considered to be the most effective and important against Corona. The main reason for this is that a person taking the vaccine in the UK had seen symptoms of some disease, due to which the trials were stopped. So far, it has not been proven whether the symptoms were caused by the vaccine or not, but in England and India, the vaccine trials have been approved to continue. It is believed that due to this delay, the Corona vaccine will hit the market early next year.
